Early phase focus Avrio Biopharmaceuticals specializes in clinical trial material manufacturing for early phase programs, presenting an opportunity to upsell full cGMP support, formulation development, and complete clinical supply management to sponsors expanding from preclinical into Phase I/II.

cGMP Full Service With a newly commissioned cGMP facility offering parenteral fill and finish, lyophilization, packaging, labeling, CMC support, and regulatory documentation, the company can be a one-stop shop for end-to-end clinical trial material needs.

Biopharma Proximity Capabilities span small molecules and biopharmaceuticals, enabling cross-sell to diverse therapeutic areas within potential customers seeking flexible manufacturing partners for both conventional small molecule and biologic trial materials.

Strategic Program Support The portfolio includes strategic clinical program management, protocol development, investigator recruitment, trial monitoring, data analysis preparation, and final regulatory submissions, offering opportunities to offer integrated clinical trial solutions and continued sponsor relationship value.

Financial and Growth Signals Current revenue range indicates a mid-market biopharma partner with room to scale; target mid-to-large sponsors in need of nimble, cost-efficient clinical material production and rapid onboarding to capture more of the trial supply chain.